Explore › Intervention › Serum glutamine measurement

Intervention

Serum glutamine measurement

Also known as: Serum glutamine level Serum glutamine level (procedure) Serum glutamine measurement Serum glutamine measurement (procedure) Serum glutamine, NGF, and VEGF as biomarkers of vincristine-induced peripheral neuropathy VIPN

3 findings 1 paper 4 related entities View in graph →

Related entities

conditions

outcomes

populations

studys

Findings (27)

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

None

null

Analysis of serum glutamine, NGF, and VEGF at each designated time point did not reveal significant associations between candidate serum biomarkers and the development of VIPN, suggesting the effect o

Effect: null

PMC5598352

Finding details → · Paper → · Graph →

Papers (1)

PMC5598352 · PMC →